CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis

被引：59
|
作者：
Narikawa, K
Misu, T
Fujihara, K
Nakashima, I
Sato, S
Itoyama, Y
机构：
[1] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan
[2] Kohnan Hosp, Dept Neurol, Sendai, Miyagi 9828523, Japan
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2004年 / 149卷 / 1-2期
关键词：
relapsing neuromyelitis optica; multiple sclerosis; chemokine;
D O I：
10.1016/j.jneuroim.2003.12.010
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The pathogenesis of relapsing neuromyelitis optica (RNMO) remains unknown. We, for the first time, studied the levels of four chemokines in the cerebrospinal fluid in RNMO with ELISA and compared the data with those in multiple sclerosis (MS) and control. CXCL10/IP-10 and CCL17/TARC were significantly elevated in both RNMO and MS. Conversely, CCL2/MCP-1 was significantly lower in MS, but not in RNMO, than in control. CCL11/Eotaxin was not different between groups. None of the four chemokines studied was significantly different between RNMO and MS. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码：182 / 186
页数：5
相关论文
共 50 条
  • [21] Exploring the relationship of relapsing myelitis with neuromyelitis optica (Devic's disease) and multiple sclerosis
    Jacob, A
    Nicholas, R
    Das, K
    Boggild, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (08): : 1225 - 1225
  • [22] Exploring the relationship of relapsing myelitis with neuromyelitis Optica (Devic's disease) and multiple sclerosis
    Jacob, A
    Nicholas, R
    Das, K
    Boggild, M
    ANNALS OF NEUROLOGY, 2004, 56 : S33 - S33
  • [23] Soluble CD26 and CD30 levels in CSF of patients with relapsing neuromyelitis optica
    Misu, T
    Fujihara, K
    Narikawa, K
    Nakashima, I
    Sato, S
    Itoyama, Y
    NEUROLOGY, 2004, 62 (07) : A380 - A381
  • [24] Serum level measurement of progranulin in relapsing-remitting multiple sclerosis and neuromyelitis optica patients
    Azadani, Niloufar Nasr
    Norouzi, Faezeh
    Hajizadeh, Mahsa
    Parsa, Sara
    Khalighinejad, Farnaz
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 8 (03): : 16 - 20
  • [25] Dynamic vessel analysis in patients with relapsing remitting multiple sclerosis and neuromyelitis optica spectrum disorder
    Banze, Nicolas
    Wicklein, Rebecca
    Kuchler, Timon
    Wolf, Elisabeth
    Aly, Lilian
    Guenthner, Roman
    Berthele, Achim
    Korn, Thomas
    Hemmer, Bernhard
    Schmaderer, Christoph
    Knier, Benjamin
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 876 - 877
  • [26] Relapsing demyelinating CNS disease in a Korean pediatric population: Multiple sclerosis versus neuromyelitis optica
    Lim, Byung Chan
    Hwang, Hee
    Kim, Ki Joong
    Hwang, Yong Seung
    Cheon, Jung-Eun
    Kim, In-One
    Kim, Ho Jin
    Chae, Jong-Hee
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (01) : 67 - 73
  • [27] Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple Sclerosis
    Yan, Li
    Kimko, Holly
    Wang, Bing
    Cimbora, Daniel
    Katz, Eliezer
    Rees, William A.
    CLINICAL PHARMACOKINETICS, 2022, 61 (03) : 387 - 400
  • [28] Cognitive impairment in neuromyelitis optica and multiple sclerosis
    Fernandez Diaz, E.
    Diaz-Maroto, I.
    Fernandez Valiente, M.
    Gomez Hontanilla, M.
    Gracia Gil, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 829 - 829
  • [29] The Relationship Between Neuromyelitis Optica (NMO), Relapsing Remitting Multiple Sclerosis (RRMS) And Systemic Autoimmunity
    Al Shahrani, Ashwaq
    Alqadi, Khalid
    Hassan, Ahmed
    Alkutbi, Abdullah
    Al Reyo, Mervat
    Wazzan, Omar
    Al Said, Youssef
    Cupler, Edward
    NEUROLOGY, 2018, 90
  • [30] Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple Sclerosis
    Li Yan
    Holly Kimko
    Bing Wang
    Daniel Cimbora
    Eliezer Katz
    William A. Rees
    Clinical Pharmacokinetics, 2022, 61 : 387 - 400
12345